Explore Similar Technologies

Maximizing rare earth element separation with Lanmodulin protein using a novel desorption technology

LLNL inventors developed a proprietary desorption technology that enabled separation of a near-adjacent panel of REEs, marking the best separation...

Insertional gene overlap for secure genetic engineering

Genetic engineering allows insertion and propagation of a foreign genetic element in a heterologous system in a variety of applications such as the...

Method of Fabricating Silicon Carbide Nanoneedles

LLNL researchers have developed an approach to form silicon carbide (and diamond) nanoneedles using plasma etching that create micro pillars followed...

Modified cyclodextrins to counteract the effects of fentanyl and related opioids

After screening at least 50 different cyclodextrins, LLNL researchers found that the drug Subetadex shows enhanced affinities for fentanyl and its...

Protein mediated immune cell engineering

Rather than using genes carried by viruses, LLNL researchers have developed an alternative approach of delivering CAR to T-cells in form of proteins...

Automated High Throughput Screening Platform

LLNL inventors have developed a method and device for the high throughput screening of various chemical and biological entities using a novel...

Portable Autonomous Bioagent Detection System

Contact
Reference Number
12606
Technical Overview

There is a critical need for distributed biothreat agent sensor networks that can operate in civilian applications. These platforms need to have several key properties: 1) they need to be capable of detecting pathogens within 1 to 2 hours, allowing for enough time to respond to an event; 2) they need to be extremely low cost to maintain, since continuous monitoring is essential for many applications; and 3) they need to have sufficient sensitivity to cover a broad geographical area; and 4) they need to have sufficient selectivity to virtually eliminate false positives. Currently available bio-weapons detection systems are designed primarily for military use. These military systems are expensive to deploy and ultimately unsuited for civilian protection.

Description

LLNL’s BioBriefcase is a compact and portable instrument capable of autonomously detecting the full spectrum of bioagents, including bacteria, viruses and toxins in the air. It uses the state of art technologies to collect, process, and analyze samples to detect, and identify genetic and protein signatures of bioagents.

Times Square
Development Status

LLNL patents cover several unique inventions in sample collection, concentration, processing and amplification, and data analysis.

U.S. Patent 8,778,663.

U.S. Patent 6,402,817.

U.S. Patent 7,188,731.

U.S. Patent 6,688,187.

Advantages

The compacted size does not compromise the performance. The BioBriefcase features rapid response, multiplex capability, small reagent consumption, relatively low cost, with high sensitivity and short response time.

Potential Applications

It is an ideal instrument for monitoring bioagents in the environment, such as in open space, inside a building or in a transit system, when quick and accurate detection is required. It is also a useful tool for defense, first responders, homeland security applications, agriculture, or environmental monitoring in factories or buildings. A simple redesign may convert it to a bench top instrument for medical diagnosis and scientific research with autonomous sampling and processing of biological samples for simultaneously measuring or identifying specific DNA/RNA or protein signatures.